Biotech Unusual Volume: Agios Pharmaceuticals (NASDAQ:AGIO), OHR (NASDAQ:OHRP), La Jolla (NASDAQ:LJPC), Aastrom Biosciences (NASDAQ:ASTM)

Agios Pharmaceuticals (NASDAQ:AGIO) was downgraded by Zacks from a “neutral” rating to an “underperform” rating in a research report issued to clients and investors on Monday, Analyst Ratings News reports. Agios Pharmaceuticals Inc (NASDAQ:AGIO) stock performance was 2.84% in last session and finished the day at $46.74. Traded volume was 983,271 million shares in the last session and the average volume of the stock remained … Continue reading Biotech Unusual Volume: Agios Pharmaceuticals (NASDAQ:AGIO), OHR (NASDAQ:OHRP), La Jolla (NASDAQ:LJPC), Aastrom Biosciences (NASDAQ:ASTM)

Richard Atkins03/1103/11

Healthcare Bullish Stocks: Agios Pharmaceuticals (NASDAQ:AGIO), Rockwell Medical (NASDAQ:RMTI), OHR Pharmaceutical (NASDAQ:OHRP), Emergent Biosolutions (NYSE:EBS)

Agios Pharmaceuticals Inc (NASDAQ:AGIO) SVP Glenn Goddard sold 17,468 shares of the stock on the open market in a transaction that occurred on Friday, March 7th. Agios Pharmaceuticals Inc (NASDAQ:AGIO) stock performance was 13.82 % in last session and finished the day at $ 45.45. Traded volume was 1,334,731 million shares in the last session and the average volume of the stock remained 283.01 million … Continue reading Healthcare Bullish Stocks: Agios Pharmaceuticals (NASDAQ:AGIO), Rockwell Medical (NASDAQ:RMTI), OHR Pharmaceutical (NASDAQ:OHRP), Emergent Biosolutions (NYSE:EBS)

Mark Doerr03/1003/10

Hot Biotech Gainers: Sangamo Biosciences (NASDAQ:SGMO), CEL-SCI Corporation (NYSEMKT:CVM), Agios Pharmaceuticals (NASDAQ:AGIO), Lpath (NASDAQ:LPTN)

HIV usually infects blood cells through a protein on their surface, a “docking station” called CCR5. A California company, Sangamo BioSciences Inc. (NASDAQ:SGMO), makes a treatment that can knock out a gene that makes CCR5. Sangamo Biosciences, Inc. (NASDAQ:SGMO) stock performance was 17.08% in last session and finished the day at $22.96. Traded volume was 11.36 million shares in the last session and the average … Continue reading Hot Biotech Gainers: Sangamo Biosciences (NASDAQ:SGMO), CEL-SCI Corporation (NYSEMKT:CVM), Agios Pharmaceuticals (NASDAQ:AGIO), Lpath (NASDAQ:LPTN)

Chris Lewis03/0703/07

Biotech Losers In News: Agios Pharmaceuticals (NASDAQ:AGIO), Cell Therapeutics (NASDAQ:CTIC), NewLink Genetics (NASDAQ:NLNK), Mirati Therapeutics (NASDAQ:MRTX)

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) present at the Cowen and Company 34th Annual Health Care Conference at the Boston Marriott Copley Place. Agios Pharmaceuticals Inc (NASDAQ:AGIO) stock performance was -5.69% in last session and finished the day at $29.48. Traded volume was 263,884 million shares in the last session and the average volume of the stock remained 254.15 million shares. Agios Pharmaceuticals Inc (NASDAQ:AGIO) insider ownership … Continue reading Biotech Losers In News: Agios Pharmaceuticals (NASDAQ:AGIO), Cell Therapeutics (NASDAQ:CTIC), NewLink Genetics (NASDAQ:NLNK), Mirati Therapeutics (NASDAQ:MRTX)

Jayne Crisman03/0403/04

Best Stocks: Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), JetBlue Airways Corporation (NASDAQ:JBLU), First Midwest Bancorp Inc. (NASDAQ:FMBI), Prothena Corporation plc (NASDAQ:PRTA), RCI Hospitality (NASDAQ:RICK)

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) announced the closing of its previously announced underwritten public offering of common stock, including the exercise in full by the underwriters of their option to purchase an additional 297,968 shares at the public offering price of $110.75 per share. The exercise of the over-allotment option brought the total number of shares of common stock sold by Agios to 2,284,423 shares and … Continue reading Best Stocks: Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), JetBlue Airways Corporation (NASDAQ:JBLU), First Midwest Bancorp Inc. (NASDAQ:FMBI), Prothena Corporation plc (NASDAQ:PRTA), RCI Hospitality (NASDAQ:RICK)

Harvey Dyer12/1712/17

Market Movers: Kosmos Energy Ltd. (NYSE:KOS), Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), Potlatch Corporation (NASDAQ:PCH), Teleflex Incorporated (NYSE:TFX), BBVA Banco Frances SA (NYSE:BFR)

Kosmos Energy (NYSE:KOS)‘s stock had its “hold” rating reissued by equities research analysts at Citigroup Inc. in a research note issued to investors on Monday. They currently have a $9.50 target price on the stock, down from their previous target price of $12.00. Kosmos Energy Ltd. (NYSE:KOS) belongs to Basic Materials sector. Its net profit margin is 25.30% and weekly performance is -15.90%. On last … Continue reading Market Movers: Kosmos Energy Ltd. (NYSE:KOS), Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), Potlatch Corporation (NASDAQ:PCH), Teleflex Incorporated (NYSE:TFX), BBVA Banco Frances SA (NYSE:BFR)

Harvey Dyer12/1112/11